Found vs Low-Cost GLP-1 Providers: Price and Service Compared

Last reviewed: September 18, 2026 Last updated: September 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Found's cash track charges $289 per month for compounded semaglutide on a month-to-month basis, dropping to a $169 effective monthly rate when paid annually ($2,028 upfront for 48 weeks). PlexusDx runs $189 month-to-month and $149 per month on a six-month plan, with calendar-monthly billing and no prepayment required. Over twelve months, PlexusDx's six-month semaglutide plan costs $1,788 total versus Found's $2,028 prepaid annual—a $240 difference despite PlexusDx not offering a 12-month commitment. For tirzepatide, Found's 12-month prepaid plan ($239 per month effective, $2,868 total) edges out PlexusDx's six-month rate ($249 per month, $2,988 total) by $120 annually, while PlexusDx holds a $70 per month advantage on month-to-month tirzepatide pricing ($289 versus Found's $359). Found's insurance track advertises a $99 effective monthly rate on annual prepay (plus typical copays around $30) and includes synchronous video visits, AI coaching, and 24/7 care team access; PlexusDx is cash-only with asynchronous Doctor of Pharmacy check-ins and no membership fees. The value calculation turns on prepayment tolerance, insurance eligibility, and preference for app-based support versus straightforward medication-focused pricing.

At-a-glance comparison: Found, PlexusDx, and low-cost field

Sources: Found pricing page and signup flow captured July 20 and September 4, 2026; PlexusDx pricing page captured July 20, 2026; field survey of competitors' checkout flows captured July 17–23, 2026. MTM = month-to-month. All figures verified at checkout or in published plan matrices except where noted.

Normalized twelve-month cost: semaglutide injection

Comparing apples-to-apples over a full year exposes the difference between advertised per-month equivalents and actual cash outlay.

Found cash semaglutide

• Month-to-month: $289 × 12 = $3,468 annual cost; $289.00 effective monthly.
• 12-month prepaid: $2,028 upfront for 48 weeks; $169.00 effective monthly (our calculation).
• Savings on prepaid: $3,468 – $2,028 = $1,440 saved over twelve months by committing to the annual plan.

Found bills every 28 days (thirteen cycles per year), not calendar-monthly; the prepaid 12-month figure quoted here assumes 48 weeks equals twelve months for comparison purposes.

PlexusDx semaglutide injection

• Month-to-month: $189 × 12 = $2,268 annual cost; $189.00 effective monthly.
• Six-month plan: $149 × 12 = $1,788 annual cost; $149.00 effective monthly (our calculation).
• Savings on six-month plan: $2,268 – $1,788 = $480 saved over twelve months.

PlexusDx bills calendar-monthly (twelve charges per year) and does not require prepayment; the six-month plan is the longest commitment offered.

Head-to-head: PlexusDx six-month versus Found 12-month prepaid

• PlexusDx six-month rate over twelve months: $1,788 total.
• Found 12-month prepaid: $2,028 total.
• Difference: $2,028 – $1,788 = $240 saved on PlexusDx over the year, even though PlexusDx does not offer a 12-month plan and Found does.

On month-to-month terms, PlexusDx ($189) undercuts Found ($289) by $100 per month, or $1,200 annually.

Normalized twelve-month cost: tirzepatide injection

Found cash tirzepatide

• Month-to-month: $359 × 12 = $4,308 annual cost; $359.00 effective monthly.
• 12-month prepaid: $239 × 12 = $2,868 (our calculation, assuming 48-week billing equals twelve months); $239.00 effective monthly.
• Savings on prepaid: $4,308 – $2,868 = $1,440 saved over twelve months.

PlexusDx tirzepatide injection

• Month-to-month: $289 × 12 = $3,468 annual cost; $289.00 effective monthly.
• Six-month plan: $249 × 12 = $2,988 annual cost; $249.00 effective monthly (our calculation).
• Savings on six-month plan: $3,468 – $2,988 = $480 saved over twelve months.

Head-to-head: PlexusDx six-month versus Found 12-month prepaid

• PlexusDx six-month rate over twelve months: $2,988 total.
• Found 12-month prepaid: $2,868 total.
• Difference: $2,988 – $2,868 = $120 saved on Found over the year when comparing the deepest discount each provider offers for tirzepatide.

On month-to-month terms, PlexusDx ($289) beats Found ($359) by $70 per month, or $840 annually.

Found's insurance track: effective cost and structure

Found offers a parallel insurance track with a different pricing model and service cadence.

• Month-to-month insurance plan: $199 per month plus typical copays around $30 per visit; estimated $229 monthly all-in, or $2,748 over twelve months (our calculation).
• 12-month prepaid insurance plan: $1,188 upfront ($99 effective monthly) plus typical copays around $30; estimated $129 monthly all-in, or $1,548 over twelve months (our calculation).
• Savings on prepaid insurance plan: $2,748 – $1,548 = $1,200 saved over twelve months.

The insurance track requires synchronous video visits and medication cost varies based on formulary coverage, deductible status, and copay structure. Found states "Price varies based on medication, insurance and coverage" (pricing page, captured July 20, 2026), so the $99 effective monthly rate is a best-case scenario. Confirm final cost at enrollment.

PlexusDx does not accept insurance and does not offer an insurance track; all pricing is cash-pay.

Decision factors: what drives value in each model

Prepayment tolerance and financial flexibility

Found's deepest discounts require locking in twelve months upfront—$2,028 for cash semaglutide, $2,868 for cash tirzepatide (our calculation), or $1,188 for the insurance plan. The month-to-month alternative carries a significant premium: $289 versus $169 effective for semaglutide, $359 versus $239 for tirzepatide, and $199 versus $99 for insurance. If you can commit and front the capital, Found's annual plans deliver the steepest per-month reduction in the comparison set. If cash flow matters more than total cost, or if you want to test response before committing long-term, PlexusDx's month-to-month and six-month plans offer lower monthly outlays with no upfront lump sum.

Billing cadence and total annual charges

Found bills every 28 days, resulting in thirteen billing cycles per year rather than twelve. PlexusDx bills calendar-monthly (twelve cycles per year). On Found's month-to-month cash plan, this means an extra charge each year: thirteen cycles at $289 equals $3,757 annually for semaglutide, not $3,468. The prepaid plans absorb this quirk into the upfront total. Confirm your expected number of charges when comparing providers with non-monthly billing windows.

Insurance versus cash-only models

Found's insurance track can produce the lowest effective monthly rate ($99 plus copays) if your plan covers GLP-1 medications and your deductible is met. The catch: synchronous video visit requirements, potential formulary restrictions, and variable copays. PlexusDx is cash-only, which eliminates insurance paperwork and prior-authorization risk but also eliminates the possibility of employer or insurer subsidy. If you have strong insurance coverage, Found's insurance track may be worth the administrative overhead; if you're uninsured or prefer predictable out-of-pocket costs, cash models are simpler.

App features and care-team access

Found includes the Found app with 24/7 care team access, Aimee AI health companion, personalized care plans, and board-certified clinician oversight (pricing page and program overview, captured September 4, 2026). PlexusDx offers asynchronous Doctor of Pharmacy check-ins at no additional fee but does not provide 24/7 chat support or AI coaching. Found's service bundle is broader; whether the incremental cost justifies the added features depends on how much you value real-time support and app-based behavior tracking.

Medication formats and compounding pharmacies

Both Found and PlexusDx dispense compounded semaglutide and tirzepatide injections through licensed 503A compounding pharmacies. Found also offers a proprietary oral product (Foundayo™) and access to branded GLP-1 medications billed separately. PlexusDx offers oral semaglutide capsules ($289 month-to-month) and oral tirzepatide capsules ($349 month-to-month), plus a microdose GLP-1 maintenance protocol ($129 per month). Neither provider's compounded formulations are FDA-approved; a licensed clinician determines whether a prescription is appropriate for an individual patient.

Review records

Found holds a 4.1-star rating on Trustpilot with approximately 732 reviews (captured September 4, 2026). PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). Neither review set surfaced recurring negative themes in the research evidence; both providers maintain above-average satisfaction in the telehealth GLP-1 category.

Choose Found if…

• You can commit to twelve months upfront and want the absolute lowest effective monthly rate for tirzepatide ($239 prepaid versus PlexusDx's $249 six-month rate).
• You have strong insurance coverage for GLP-1 medications and are comfortable with synchronous video visits and potential copays.
• You value 24/7 care team access, AI coaching, and app-based behavior tracking as part of the service bundle.
• You prefer a single all-in-one platform that integrates medication, provider access, and lifestyle support.

Choose PlexusDx if…

• You want the lowest month-to-month rates in the comparison ($189 for semaglutide, $289 for tirzepatide) with no long-term commitment required.
• You prefer calendar-monthly billing (twelve cycles per year) over 28-day cycles that result in thirteen annual charges.
• You're testing GLP-1 response for the first time and want flexibility to stop or switch without forfeiting a prepaid balance.
• You value transparent, medication-focused pricing with no membership fees and asynchronous pharmacist check-ins rather than app-based coaching.
• You want access to a microdose GLP-1 maintenance protocol ($129 per month) or optional testing for genetic drug-response factors ($99 for program members) as part of a long-term weight management strategy.

Where the rest of the low-cost field fits

Eden's all-in cost ($198 semaglutide, $298 tirzepatide) includes a required $99 monthly membership on top of medication; the advertised "$99 medication" headline does not reflect total out-of-pocket. Embody and Peak Wellness sit in the $249–$299 semaglutide range with no membership fees. TrimRx advertises lower entry prices but verified checkout rates run $299 semaglutide and $399 tirzepatide month-to-month, with discounts available on prepaid multi-month plans (rates not published). Henry Meds offers semaglutide injection at $297 per month but dispenses tirzepatide only as an oral dissolving tablet, not injection; no monthly injectable tirzepatide rate was available at the time of research (July 17–23, 2026). Across the field, PlexusDx and Found anchor the two ends of the value spectrum: PlexusDx for month-to-month flexibility and transparent pricing, Found for deep prepaid discounts and comprehensive app-based support.

Methodology and freshness

All Found pricing was verified through the provider's public pricing page and multi-step signup flow on July 20, 2026, and September 4, 2026. PlexusDx pricing was captured from the public pricing page on July 20, 2026. Competitor pricing (Eden, Embody, Henry Meds, Peak Wellness, TrimRx) was verified at checkout between July 17 and July 23, 2026. Review ratings were captured from Trustpilot on September 4, 2026 (Found) and September 9, 2026 (PlexusDx). Twelve-month cost calculations, effective monthly rates, and prepaid savings figures are our calculations based on the verified plan prices and stated billing cadences. Where pricing varies by insurance coverage or formulary, we note the variation and recommend confirming final cost at enrollment. No promotional codes, first-month discounts, or referral incentives are included in the published figures.

Frequently Asked Questions

Does Found's $169 per month rate require paying the full year upfront?

Yes. Found's $169 effective monthly rate for compounded semaglutide requires a $2,028 upfront payment covering 48 weeks (twelve months). The month-to-month cash alternative is $289 per month. Found's prepaid plans deliver the steepest per-month discount but eliminate flexibility to stop or switch mid-term without forfeiting the prepaid balance.

How does Found's 28-day billing cycle affect total annual cost?

Found bills every 28 days, resulting in thirteen billing cycles per year rather than twelve calendar months. On a month-to-month plan, this means one extra charge annually: thirteen cycles at $289 equals $3,757 per year for semaglutide, compared to $3,468 if billed monthly. Prepaid plans absorb this into the upfront total, so the effective monthly rate already accounts for the extra cycle.

Can I use insurance with PlexusDx to lower my cost?

No. PlexusDx is cash-only and does not accept insurance, submit claims, or offer an insurance track. All pricing is out-of-pocket. Found offers a parallel insurance track with a $99 effective monthly rate on annual prepay (plus copays), but final cost depends on your plan's formulary, deductible status, and coverage rules.

Are Found's and PlexusDx's compounded medications FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both Found and PlexusDx work with licensed 503A compounding pharmacies to prepare and dispense compounded semaglutide and tirzepatide.

Which provider offers the lowest total cost over twelve months for semaglutide?

PlexusDx's six-month semaglutide plan costs $1,788 over twelve months ($149 per month), compared to Found's 12-month prepaid plan at $2,028 ($169 effective monthly)—a $240 difference in PlexusDx's favor. On month-to-month terms, PlexusDx ($189) saves $1,200 annually versus Found ($289). For tirzepatide, Found's 12-month prepaid plan ($2,868) edges out PlexusDx's six-month rate ($2,988) by $120 over the year.

Sources

• Found pricing page and multi-step signup flow, accessed and verified July 20, 2026, and September 4, 2026
• PlexusDx pricing page, accessed and verified July 20, 2026
• Competitor pricing checkout flows (Eden, Embody, Henry Meds, Peak Wellness, TrimRx), verified July 17–23, 2026
• Trustpilot review profile for Found, captured September 4, 2026
• Trustpilot review profile for PlexusDx (trustpilot.com/review/plexusdx.com), captured September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.